// App-Quantinova.ai

WP012 : Non-TBI-containing Conditioing in Children with Acute Lymphoblastic Leukemia. An analysis on behalf of the Paediatric Diseases Working Party

Researchers

Presenter

  • C. Peters

Principal Investigators

  • P. Sedlacek

  • J.-H. Dalle

Medical Centers

  • University Hospital Frankfurt, Frankfurt, Germany

  • University Hospital Motol, Prague, Czech Republic

  • University Debre, Paris, France,

  • St. Anna Children s Hospital, Vienna, Austria

Locations

  • France

  • Germany

  • Czech Republic

  • Austria

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Acute lymphoblastic leukemia

  • Graft-versus-host disease

Biomarkers

  • Breakpoint Cluster Region

Drug/Treatment

  • Cyclophosphamide

  • Cyclophosphamide Injection

  • fludarabine tablet

  • Etoposide

  • Etoposide phosphate

  • Melphalan

  • Busulfan

  • Thiotepa

  • thiocoraline

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved